5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rapid diagnostic testing for onchocerciasis in Maridi (South Sudan) before and after improving elimination strategies: a repeated cross-sectional survey

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Maridi County is an onchocerciasis-endemic area in South Sudan. Annual community-directed treatment with ivermectin (CDTi) was instituted in Maridi since the early 2000s, but with low coverage. In 2021, the CDTi programme was strengthened to a six-monthly programme. Additionally, the community-based vector control strategy “Slash and Clear” has been implemented since 2019 at the Maridi Dam, the only blackfly breeding site in the area. This study assessed the effect of these reinforced onchocerciasis elimination interventions on the Onchocerca volvulus seroprevalence among young children, an indicator of ongoing transmission.

          Methods

          Baseline and follow-up serosurveys were conducted in Maridi in 2019 (prior to strengthening onchocerciasis elimination efforts) and 2023, respectively. During both surveys, children aged three to nine years were recruited from five study sites situated at different distances from the Maridi Dam. Ov16 antibodies were detected via rapid diagnostic tests (RDTs) using whole blood obtained by finger-pricking the participants. Baseline and follow-up Ov16 prevalence rates were calculated and compared.

          Results

          In 2019, the Ov16 seroprevalence among children aged three to nine years was 24.5% compared to 30.6% in 2023 (p=0.22). Both surveys found a particularly high Ov16 seroprevalence in the study site closest to the Maridi Dam (35.0% in 2019 and 44.0% in 2023, p=0.52). The Ov16 seroprevalence had a non-significant decreasing trend in the three-year-old children, from 12.5% (3/24) in 2019 to 8.8% (3/34) in 2023 (p=0.65).

          Conclusion

          The persistent Ov16 RDT seropositivity among three-year-old children in 2023 indicates ongoing O. volvulus transmission. Therefore, further strengthening of the onchocerciasis elimination programme is required. The study highlights the utility of RDTs in monitoring onchocerciasis transmission in highly endemic settings.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Alternative treatment strategies to accelerate the elimination of onchocerciasis

          Abstract The use of alternative (or complementary) treatment strategies (ATSs) i.e. differing from annual community-directed treatment with ivermectin (CDTI) is required in some African foci to eliminate onchocerciasis by 2025. ATSs include vector control, biannual or pluriannual CDTI, better timing of CDTI, community-directed treatment with combinations of currently available anthelminthics or new drugs, and ‘test-and-treat’ (TNT) strategies requiring diagnosis of infection and/or contraindications to treatment for decisions on who to treat with what regimen. Two TNT strategies can be considered. Loa-first TNT, designed for loiasis-endemic areas and currently being evaluated using a rapid test (LoaScope), consists of identifying individuals with levels of Loa microfilaremia associated with a risk of post-ivermectin severe adverse events to exclude them from ivermectin treatment and in treating the rest (usually >97%) of the population safely. Oncho-first TNT consists of testing community members for onchocerciasis before giving treatment (currently ivermectin or doxycycline) to those who are infected. The choice of the ATS depends on the prevalences and intensities of infection with Onchocerca volvulus and Loa loa and on the relative cost-effectiveness of the strategies for the given epidemiological situation. Modelling can help select the optimal strategies, but field evaluations to determine the relative cost-effectiveness are urgently needed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection.

            Onchocerciasis (river blindness) is a serious health problem and a severe obstacle to social and economic development, especially in Africa. A complementary DNA fragment coding for an Onchocerca volvulus antigen (OV-16) was cloned and expressed in the plasmid vector pCG808fx. Immune responses to this O. volvulus-specific recombinant antigen were detectable in patients with documented onchocerciasis; the antibody response was also detectable at 3 months and at more than 1 year before infection could otherwise be detected in humans and in chimpanzees experimentally infected with O. volvulus third-stage larvae.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey

              Highlights • An epilepsy prevalence of 4.4% was observed in villages in Maridi. • Living close to the Maridi river is a major risk factor for epilepsy. • Persons with nodding seizures and with other forms of epilepsy live in the same areas. • Ivermectin coverage needs to increase to prevent onchocerciasis associated epilepsy.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data CurationRole: Formal AnalysisRole: InvestigationRole: MethodologyRole: SoftwareRole: VisualizationRole: Writing – Original Draft PreparationRole: Writing – Review & Editing
                Role: ConceptualizationRole: Data CurationRole: InvestigationRole: MethodologyRole: Project AdministrationRole: Writing – Review & Editing
                Role: Writing – Review & Editing
                Role: ConceptualizationRole: Funding AcquisitionRole: MethodologyRole: ResourcesRole: SupervisionRole: ValidationRole: Writing – Original Draft PreparationRole: Writing – Review & Editing
                Role: Writing – Review & Editing
                Role: Formal AnalysisRole: SupervisionRole: Writing – Original Draft PreparationRole: Writing – Review & Editing
                Journal
                Open Res Eur
                Open Res Eur
                Open Research Europe
                F1000 Research Limited (London, UK )
                2732-5121
                22 March 2024
                2023
                : 3
                : 206
                Affiliations
                [1 ]Global Health Institute, University of Antwerp, Antwerp, Flanders, 2610, Belgium
                [2 ]Amref Health Africa South Sudan, Juba, South Sudan
                [3 ]Neglected Tropical Diseases Programme, Ministry of Health, Juba, South Sudan
                [1 ]Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso
                [1 ]Emory University, Atlanta, Georgia, USA
                Global Health institute, University of Antwerp, Antwerp, Flanders, Belgium
                [1 ]Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso
                Global Health institute, University of Antwerp, Antwerp, Flanders, Belgium
                [1 ]Department Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
                Global Health institute, University of Antwerp, Antwerp, Flanders, Belgium
                Author notes

                No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Author information
                https://orcid.org/0000-0003-1207-5811
                https://orcid.org/0000-0001-8155-9014
                https://orcid.org/0000-0002-1919-1340
                https://orcid.org/0000-0003-3544-1239
                Article
                10.12688/openreseurope.16093.2
                11016167
                38617116
                388c064c-2653-4cbe-9742-8f89149310b6
                Copyright: © 2024 Hadermann A et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 29 February 2024
                Funding
                Funded by: FIND
                Funded by: 'la Caixa' Foundation
                Award ID: B005782
                Funded by: Horizon Europe Framework Programme
                Award ID: 768815
                Funded by: Fonds Wetenschappelijk Onderzoek
                Award ID: 1296723N
                RC received funding from the European Research Council, grant number 768815 and FIND. L-JA had funding from La Caixa Foundation, grant number B005782. JNSF and RC received funding from the Research Foundation – Flanders (FWO), grant number: 1296723N and G0A0522N, respectively. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.
                Categories
                Research Article
                Articles

                onchocerciasis,onchocerca volvulus,antibodies,transmission,testing,seroprevalence,children,ivermectin,vector control

                Comments

                Comment on this article